Secondary Logo

Journal Logo

Articles by Charles L. Loprinzi, MD

North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes

Park, Haeseong; Qin, Rui; Smith, Thomas J.; More

Menopause. 22(6):627-632, June 2015.

A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7

Pruthi, Sandhya; Qin, Rui; Terstreip, Shelby A.; More

Menopause: The Journal of The North American Menopause Society. 19(1):48-53, January 2012.

Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration

Loprinzi, Charles L.; Diekmann, Brent; Novotny, Paul J.; More

Menopause. 16(5):883-887, September-October 2009.

Newer antidepressants for hot flashes-should their efficacy still be up for debate?

Loprinzi, Charles L.; Barton, Debra L.; Sloan, Jeff A.; More

Menopause. 16(1):184-187, January 2009.

Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience

Loprinzi, Charles L.; Barton, Debra L.; Sloan, Jeff A.; More

Menopause. 15(4):655-660, July-August 2008.